inMOTIFin: a lightweight end-to-end simulation software for regulatory sequences
Katalin Ferenc1, Lorenzo Martini1,2, Ieva Rauluseviciute1
1Norwegian Centre for Molecular Biosciences and Medicine (NCMBM), Nordic EMBL Partnership, University of Oslo, Oslo 0318, Norway.
Bioinformatics (Oxford, England)
|January 20, 2026
Summary
inMOTIFin is a new Python software for simulating and modifying DNA regulatory sequences. It aids in developing and assessing bioinformatics tools for transcriptional regulatory grammar analysis.
Area of Science:
- Bioinformatics
- Computational Biology
- Genomics
Background:
- Accurate analysis of transcriptional regulatory grammars requires controlled simulations for method validation.
- Existing simulation tools often lack flexibility and integration ease, hindering practical application.
Purpose of the Study:
- To introduce inMOTIFin, a user-friendly Python software for simulating and modifying DNA regulatory sequences.
- To provide a versatile and efficient tool for developing and assessing bioinformatics frameworks for transcriptional regulatory grammar analysis.
Main Methods:
- inMOTIFin offers modular and flexible simulation of regulatory sequences.
- It allows customizable generation of motifs, precise control over motif instances (position, co-occurrence, spacing), and direct modification of real sequences.
- The software is implemented in Python and available via PyPI and Docker Hub.
Main Results:
- inMOTIFin facilitates the creation of controlled datasets for evaluating motif discovery algorithms.
- It supports the analysis of transcription factor cooperativity and aids in explaining deep learning models for gene regulation.
- The software ensures robust and reproducible analyses of transcriptional regulatory grammars.
Conclusions:
- inMOTIFin addresses limitations of existing simulators, offering enhanced flexibility and ease of use.
- It is a valuable tool for the accurate development, assessment, and interpretation of bioinformatics frameworks for transcriptional regulatory grammars.
- The software promotes robust and reproducible research in the field.
More Related Videos
Related Concept Videos
Cis-regulatory Sequences
11.6K
Cis-regulatory sequences are short fragments of non-coding DNA that are present on the same chromosomes as the genes that they regulate. These fragments serve as binding sites for transcriptional regulators, proteins that are responsible for controlling gene transcription and differential gene expression across cell types in eukaryotes. Cis-regulatory sequences can be close to the gene of interest or thousands of bases away in the DNA sequence; however, those sequences that are further away are...
11.6K
Cis-regulatory Sequences
4.0K
4.0K
Global Regulatory Systems
623
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
623
Sanger Sequencing
773.5K
DNA sequencing is a fundamental technique that is routinely used in the biological sciences. This method can be applied to a range of questions at different scales - from the sequencing of a cloned DNA fragment or the study of a mutation in a gene up to whole-genome sequencing. However, despite the widespread use of sequencing today, it was not until 1977 that Fredrick Sanger and his collaborators developed the chain-termination method to decode DNA sequences. It relies on the separation of a...
773.5K
Drug Control Governance: Regulatory Bodies and Their Impact
503
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
503
Statistical Software for Data Analysis and Clinical Trials
1.4K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.4K


